,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.1,Insomnia,6,16505782
1,22.1,Anaemia,3,16505782
2,22.1,Product dose omission,6,16505782
3,22.1,Neoplasm malignant,6,16505782
4,22.1,Taste disorder,6,16505782
5,22.1,Joint swelling,3,16505782
6,22.1,Drug ineffective,6,16505782
7,22.1,Nocturia,6,16505782
0,22.0,Back pain,3,16505783
1,22.0,Pain in extremity,3,16505783
2,22.0,Limb discomfort,3,16505783
3,22.0,Asthenia,3,16505783
4,22.0,Dizziness,6,16505783
5,22.0,Fatigue,3,16505783
0,22.0,Rash,6,16505784
1,22.0,Benign neoplasm,6,16505784
2,22.0,Vision blurred,2,16505784
0,22.1,Alopecia,6,16505788
1,22.1,Neuropathy peripheral,6,16505788
2,22.1,Blood magnesium decreased,6,16505788
3,22.1,Adverse event,6,16505788
4,22.1,Laboratory test abnormal,6,16505788
5,22.1,Pain in extremity,6,16505788
6,22.1,Rosacea,6,16505788
7,22.1,Pruritus,6,16505788
8,22.1,Malignant neoplasm progression,6,16505788
0,22.1,Muscular weakness,3,16505789
1,22.1,Diarrhoea,6,16505789
2,22.1,Decreased appetite,6,16505789
3,22.1,Dizziness,6,16505789
4,22.1,Haemoglobin decreased,6,16505789
5,22.1,Rash pruritic,6,16505789
6,22.1,White blood cell count decreased,6,16505789
7,22.1,Haematocrit decreased,6,16505789
8,22.1,Fatigue,3,16505789
9,22.1,Drug ineffective,6,16505789
10,22.1,Red blood cell count decreased,6,16505789
0,22.0,Nausea,3,16505790
0,22.1,Mood altered,3,16505792
1,22.1,Hot flush,3,16505792
2,22.1,Decreased appetite,3,16505792
3,22.1,Dizziness,3,16505792
4,22.1,Photosensitivity reaction,3,16505792
5,22.1,Haemoglobin decreased,6,16505792
6,22.1,Transfusion,6,16505792
7,22.1,Hypophagia,3,16505792
8,22.1,Malaise,3,16505792
9,22.1,White blood cell count decreased,3,16505792
10,22.1,Retching,3,16505792
11,22.1,Red blood cell count decreased,3,16505792
12,22.1,Nausea,3,16505792
13,22.1,Abdominal pain upper,3,16505792
0,22.1,Depression,3,16505801
1,22.1,Diarrhoea,2,16505801
2,22.1,Asthenia,3,16505801
3,22.1,Pain,2,16505801
4,22.1,Vomiting,2,16505801
5,22.1,Influenza like illness,6,16505801
6,22.1,Anxiety,3,16505801
7,22.1,Polydipsia,6,16505801
8,22.1,Thirst,6,16505801
9,22.1,Abdominal pain,2,16505801
10,22.1,Dysgeusia,3,16505801
11,22.1,Constipation,3,16505801
12,22.1,Insomnia,2,16505801
13,22.1,Blood chloride abnormal,6,16505801
14,22.1,Carbohydrate antigen 125 increased,6,16505801
15,22.1,Hepatic enzyme increased,2,16505801
16,22.1,Haemoglobin decreased,2,16505801
17,22.1,Decreased appetite,6,16505801
18,22.1,Dizziness,3,16505801
19,22.1,Nausea,2,16505801
20,22.1,Blood creatinine increased,6,16505801
21,22.1,Fatigue,2,16505801
0,22.0,Toxicity to various agents,6,16505802
1,22.0,Drug intolerance,6,16505802
0,22.0,Malignant neoplasm progression,6,16505804
0,22.1,Malignant neoplasm progression,3,16505806
1,22.1,Drug ineffective,6,16505806
0,22.0,Peripheral swelling,6,16505807
1,22.0,Vomiting,1,16505807
2,22.0,Malignant neoplasm progression,3,16505807
3,22.0,Constipation,6,16505807
4,22.0,Therapy non-responder,6,16505807
0,22.1,Back pain,3,16505816
1,22.1,Heart rate increased,2,16505816
2,22.1,Vomiting,3,16505816
3,22.1,Pain in extremity,6,16505816
4,22.1,Hyperglycaemia,6,16505816
5,22.1,Constipation,3,16505816
6,22.1,Arthralgia,6,16505816
7,22.1,Bone disorder,2,16505816
8,22.1,Spinal pain,3,16505816
9,22.1,Death,5,16505816
10,22.1,Blood sodium decreased,3,16505816
11,22.1,Nausea,3,16505816
12,22.1,Appetite disorder,1,16505816
13,22.1,Fatigue,3,16505816
14,22.1,Weight decreased,6,16505816
15,22.1,Headache,2,16505816
16,22.1,Hypertension,2,16505816
17,22.1,Dehydration,3,16505816
18,22.1,Blood magnesium decreased,3,16505816
19,22.1,Mucous stools,2,16505816
20,22.1,Flatulence,2,16505816
21,22.1,Gastrooesophageal reflux disease,3,16505816
22,22.1,Blood calcium increased,2,16505816
23,22.1,Haemoglobin decreased,3,16505816
24,22.1,Chest pain,6,16505816
25,22.1,Sinus tachycardia,6,16505816
26,22.1,Product use in unapproved indication,3,16505816
27,22.1,Palpitations,6,16505816
0,22.0,Ovarian cancer recurrent,3,16505831
1,22.0,Carbohydrate antigen 125 increased,6,16505831
0,22.0,Blood urine present,3,16505832
1,22.0,Urinary tract infection,3,16505832
0,22.0,Product use in unapproved indication,6,16505833
0,22.0,Abdominal pain,1,16505834
0,22.0,Diarrhoea,6,16505836
0,22.0,Blood bilirubin increased,6,16505837
0,22.0,Dyspepsia,1,16505845
1,22.0,Insomnia,1,16505845
2,22.0,Muscle spasms,6,16505845
0,22.0,Dyspnoea,6,16505846
0,22.0,Product dose omission,6,16505847
0,22.0,Therapy partial responder,6,16505848
0,22.0,Blood creatinine increased,6,16505849
1,22.0,Abdominal pain,6,16505849
2,22.0,Treatment noncompliance,6,16505849
3,22.0,Malignant neoplasm progression,6,16505849
0,22.0,Fatigue,3,16505851
1,22.0,Insomnia,3,16505851
2,22.0,Feeling of body temperature change,3,16505851
3,22.0,Restlessness,3,16505851
0,22.0,Tenderness,3,16505852
1,22.0,Pain in extremity,3,16505852
0,22.1,Upper-airway cough syndrome,3,16505853
1,22.1,Restless legs syndrome,6,16505853
2,22.1,Constipation,3,16505853
3,22.1,Dysgeusia,6,16505853
4,22.1,Nausea,3,16505853
5,22.1,Therapeutic response unexpected,6,16505853
6,22.1,Carbohydrate antigen 125 increased,6,16505853
7,22.1,Adverse event,6,16505853
8,22.1,Feeling abnormal,6,16505853
9,22.1,Fatigue,3,16505853
10,22.1,Therapy partial responder,6,16505853
11,22.1,Secretion discharge,6,16505853
0,22.0,Diarrhoea,6,16505854
1,22.0,Cough,3,16505854
2,22.0,Constipation,6,16505854
3,22.0,Blood count abnormal,6,16505854
4,22.0,Carbohydrate antigen 125 increased,6,16505854
5,22.0,Haemoglobin decreased,6,16505854
0,22.0,Malignant neoplasm progression,6,16505855
0,22.0,Abdominal pain,6,16505856
0,22.0,Diarrhoea,6,16505857
0,22.0,Carbohydrate antigen 125 increased,6,16505858
0,22.0,Blood bilirubin unconjugated increased,6,16505859
1,22.0,Anaemia,6,16505859
2,22.0,Blood bilirubin increased,6,16505859
0,22.0,Liver function test increased,1,16505860
1,22.0,Carbohydrate antigen 125 increased,6,16505860
0,22.0,Drug ineffective,6,16505861
0,22.0,Malignant neoplasm progression,6,16505881
0,22.0,Fatigue,3,16505882
0,22.0,Superficial injury of eye,6,16505883
1,22.0,Eye pain,6,16505883
0,22.0,Decreased appetite,3,16505884
1,22.0,Heart rate increased,3,16505884
2,22.0,Pleural effusion,3,16505884
3,22.0,Lymphadenopathy,3,16505884
4,22.0,Malignant neoplasm progression,6,16505884
0,22.0,Product dose omission,6,16505885
1,22.0,Accidental underdose,6,16505885
0,22.0,Haemoglobin decreased,6,16505886
1,22.0,Platelet count decreased,6,16505886
0,22.0,Dizziness,6,16505887
1,22.0,Retching,6,16505887
0,22.0,Blood creatinine increased,6,16505888
1,22.0,Anaemia,6,16505888
0,22.0,Taste disorder,6,16505889
0,22.0,Malignant neoplasm progression,6,16505890
0,22.0,Platelet count decreased,3,16505891
0,22.0,White blood cell count decreased,3,16505892
1,22.0,Platelet count decreased,6,16505892
0,22.0,Productive cough,6,16505894
1,22.0,Dysphonia,6,16505894
2,22.0,Oropharyngeal pain,6,16505894
0,22.0,Taste disorder,6,16505895
1,22.0,Nausea,6,16505895
2,22.0,Headache,6,16505895
0,22.0,Dysphonia,6,16505896
1,22.0,Oropharyngeal pain,6,16505896
0,22.0,Pyrexia,3,16505897
1,22.0,Adverse event,6,16505897
0,22.0,Decreased appetite,6,16505898
1,22.0,Nausea,6,16505898
2,22.0,Oral pain,6,16505898
0,22.0,Arthralgia,3,16505899
0,22.0,Fatigue,3,16505901
1,22.0,Nausea,3,16505901
0,22.0,Oropharyngeal pain,6,16505903
1,22.0,Product use in unapproved indication,6,16505903
0,22.0,Platelet count decreased,6,16505904
0,22.1,Tinnitus,3,16505920
1,22.1,Hypoaesthesia,6,16505920
0,22.0,Laboratory test abnormal,6,16505926
0,22.0,Laboratory test abnormal,6,16505927
1,22.0,Carbohydrate antigen 125 increased,3,16505927
2,22.0,Malignant neoplasm progression,6,16505927
3,22.0,Tumour marker increased,3,16505927
0,22.0,Fatigue,3,16505928
1,22.0,Asthenia,3,16505928
0,22.0,Fatigue,3,16505929
0,22.0,Pyrexia,1,16505930
1,22.0,Dyspnoea,1,16505930
2,22.0,Palpitations,1,16505930
3,22.0,Stomatitis,1,16505930
4,22.0,Rash,2,16505930
5,22.0,Fatigue,1,16505930
6,22.0,Asthenia,1,16505930
7,22.0,Dyspnoea,1,16505930
8,22.0,Chest discomfort,2,16505930
0,22.1,Amnesia,6,16505945
1,22.1,Flatulence,3,16505945
2,22.1,Abdominal pain,2,16505945
3,22.1,Fatigue,2,16505945
4,22.1,Dizziness,3,16505945
5,22.1,Headache,2,16505945
0,22.0,Nausea,6,16505946
0,22.0,Computerised tomogram abnormal,6,16505947
1,22.0,Memory impairment,6,16505947
0,22.0,Oral pain,3,16505948
0,22.0,Fatigue,6,16505949
0,22.0,White blood cell count decreased,6,16505950
1,22.0,Pyrexia,2,16505950
2,22.0,Malignant neoplasm progression,3,16505950
3,22.0,Taste disorder,2,16505950
0,22.0,Insomnia,1,16505952
1,22.0,Paraesthesia,1,16505952
2,22.0,Pain,2,16505952
3,22.0,Abdominal pain,1,16505952
4,22.0,Feeling abnormal,1,16505952
0,22.0,Dehydration,6,16505953
1,22.0,Diarrhoea,1,16505953
0,22.0,Drug intolerance,6,16505954
0,22.0,Platelet count decreased,6,16505955
0,22.0,Drug ineffective,6,16505956
0,22.0,Vomiting,6,16505957
1,22.0,Nausea,6,16505957
0,22.0,Headache,3,16505958
1,22.0,Nausea,6,16505958
0,22.0,Blood creatinine increased,6,16505959
1,22.0,Fatigue,6,16505959
2,22.0,Malignant neoplasm progression,6,16505959
3,22.0,Oedema peripheral,6,16505959
0,22.0,Fatigue,3,16505960
1,22.0,Asthenia,3,16505960
2,22.0,Secretion discharge,3,16505960
3,22.0,Cough,3,16505960
4,22.0,Blood creatinine increased,3,16505960
0,22.0,Accidental underdose,6,16505961
0,22.0,Carbohydrate antigen 125 increased,6,16505962
1,22.0,Diarrhoea,6,16505962
2,22.0,Fatigue,3,16505962
3,22.0,Therapy partial responder,6,16505962
4,22.0,Malignant neoplasm progression,6,16505962
0,22.1,Scan abnormal,6,16505964
1,22.1,Constipation,3,16505964
2,22.1,Carbohydrate antigen 125 increased,3,16505964
3,22.1,Depression,3,16505964
4,22.1,Fatigue,3,16505964
5,22.1,Positron emission tomogram abnormal,6,16505964
6,22.1,Weight increased,6,16505964
0,22.0,Limb discomfort,3,16505965
1,22.0,Arthritis,3,16505965
0,22.0,Splenic injury,1,16505966
1,22.0,Eosinophil count decreased,6,16505966
2,22.0,Blood alkaline phosphatase increased,6,16505966
3,22.0,Cough,6,16505966
4,22.0,Alanine aminotransferase increased,6,16505966
5,22.0,Red cell distribution width increased,6,16505966
6,22.0,Blood albumin decreased,6,16505966
7,22.0,Haematocrit decreased,6,16505966
8,22.0,Haemoglobin decreased,6,16505966
9,22.0,Red blood cell count decreased,6,16505966
10,22.0,Pleural effusion,6,16505966
11,22.0,Insomnia,6,16505966
12,22.0,Lymphocyte count decreased,6,16505966
0,22.1,Fatigue,6,16505967
1,22.1,Dyspnoea,3,16505967
2,22.1,Decreased appetite,3,16505967
3,22.1,Abdominal pain,6,16505967
4,22.1,Fatigue,1,16505967
5,22.1,Abdominal pain upper,3,16505967
6,22.1,Haematochezia,1,16505967
7,22.1,Haematochezia,3,16505967
0,22.0,Adverse event,6,16505968
1,22.0,Malignant neoplasm progression,6,16505968
0,22.0,Drug ineffective,6,16505971
1,22.0,Fatigue,3,16505971
0,22.0,Nausea,2,16505972
0,22.0,Weight decreased,3,16505973
1,22.0,Decreased appetite,3,16505973
2,22.0,Fatigue,3,16505973
3,22.0,Feeling abnormal,3,16505973
4,22.0,Nausea,3,16505973
0,22.0,Constipation,3,16505974
0,22.0,Anaemia,6,16505975
0,22.1,Fatigue,2,16505976
1,22.1,Dry skin,6,16505976
2,22.1,Nausea,6,16505976
3,22.1,Anaemia,2,16505976
4,22.1,Photosensitivity reaction,6,16505976
0,22.0,Rash,3,16505995
0,22.0,Hepatic enzyme increased,6,16505996
1,22.0,Sunburn,3,16505996
0,22.0,Lymphoedema,6,16505997
1,22.0,Hypertension,6,16505997
0,22.0,Renal function test abnormal,3,16505998
1,22.0,Liver function test increased,3,16505998
2,22.0,Gastrointestinal sounds abnormal,3,16505998
3,22.0,Abdominal pain upper,6,16505998
0,22.0,Recurrent cancer,6,16505999
0,22.1,Fatigue,3,16506001
1,22.1,Nausea,3,16506001
2,22.1,Product dose omission,6,16506001
0,22.0,Product dose omission,6,16506002
0,22.0,White blood cell count decreased,3,16506006
0,22.1,Fatigue,3,16506007
1,22.1,Gallbladder disorder,6,16506007
2,22.1,Arthralgia,2,16506007
3,22.1,Abdominal hernia,6,16506007
4,22.1,Muscle tightness,3,16506007
5,22.1,Anxiety,6,16506007
6,22.1,Carbohydrate antigen 125 increased,3,16506007
7,22.1,Hepatic enzyme increased,2,16506007
8,22.1,Procedural pain,6,16506007
9,22.1,Depression,6,16506007
10,22.1,Taste disorder,6,16506007
11,22.1,Product dose omission,6,16506007
0,22.1,Pruritus,3,16506008
0,22.0,Neoplasm,3,16506010
0,22.1,Dyspnoea exertional,6,16506011
1,22.1,Platelet count decreased,3,16506011
2,22.1,White blood cell count decreased,6,16506011
3,22.1,Nausea,6,16506011
4,22.1,Red blood cell count decreased,1,16506011
0,22.0,Product use in unapproved indication,6,16506013
1,22.0,Dysgeusia,3,16506013
2,22.0,Joint swelling,3,16506013
3,22.0,Constipation,6,16506013
0,22.0,Paronychia,3,16506014
1,22.0,Rash,2,16506014
0,22.0,Computerised tomogram abnormal,6,16506026
0,22.0,Arthralgia,3,16506034
1,22.0,Fatigue,3,16506034
2,22.0,Motion sickness,3,16506034
3,22.0,Feeling abnormal,3,16506034
4,22.0,Abdominal pain upper,1,16506034
5,22.0,Vomiting,1,16506034
6,22.0,Neck pain,3,16506034
7,22.0,Carbohydrate antigen 125 increased,3,16506034
8,22.0,Pain in extremity,3,16506034
9,22.0,Myalgia,3,16506034
10,22.0,Nausea,1,16506034
0,22.0,Drug intolerance,6,16506035
1,22.0,Toxicity to various agents,6,16506035
0,22.0,Anger,2,16506036
1,22.0,Constipation,1,16506036
2,22.0,Back pain,2,16506036
3,22.0,Feeling abnormal,2,16506036
4,22.0,Gastrointestinal disorder,1,16506036
5,22.0,Dyspepsia,2,16506036
6,22.0,Diarrhoea,2,16506036
7,22.0,Flatulence,1,16506036
8,22.0,Headache,3,16506036
0,22.0,Photosensitivity reaction,6,16506037
1,22.0,Pruritus,6,16506037
2,22.0,Rash,1,16506037
0,22.0,Fatigue,6,16506038
1,22.0,Liver function test increased,6,16506038
0,22.0,Peripheral swelling,3,16506039
0,22.1,Thirst,3,16506040
1,22.1,Dyspnoea,3,16506040
2,22.1,Fatigue,3,16506040
3,22.1,Hiccups,3,16506040
4,22.1,Anaemia,3,16506040
0,22.0,Ulcer,6,16506041
0,22.1,Flatulence,3,16506043
1,22.1,Peripheral swelling,3,16506043
2,22.1,Dyspepsia,3,16506043
3,22.1,Nausea,3,16506043
4,22.1,Seasonal allergy,6,16506043
5,22.1,Abdominal distension,3,16506043
6,22.1,Alopecia,3,16506043
7,22.1,Madarosis,3,16506043
8,22.1,Productive cough,2,16506043
9,22.1,Dry mouth,3,16506043
10,22.1,Abdominal discomfort,3,16506043
0,22.0,Fatigue,3,16506044
1,22.0,Diarrhoea,3,16506044
2,22.0,Nausea,2,16506044
3,22.0,Headache,2,16506044
0,22.0,Rash,6,16506045
1,22.0,Erythema,6,16506045
2,22.0,Lethargy,6,16506045
3,22.0,Dehydration,6,16506045
4,22.0,Decreased appetite,6,16506045
5,22.0,Hypersensitivity,6,16506045
6,22.0,Adverse event,3,16506045
7,22.0,Hypersensitivity,1,16506045
8,22.0,Fatigue,6,16506045
9,22.0,Asthenia,6,16506045
10,22.0,Nausea,6,16506045
0,22.1,Dyspnoea exertional,6,16506046
1,22.1,Fatigue,6,16506046
2,22.1,Urinary tract infection,6,16506046
3,22.1,Platelet count decreased,3,16506046
4,22.1,Product dose omission,6,16506046
5,22.1,Abdominal distension,3,16506046
6,22.1,Tumour marker increased,6,16506046
7,22.1,Contusion,6,16506046
8,22.1,Malignant neoplasm progression,6,16506046
0,22.0,Drug intolerance,6,16506052
1,22.0,Toxicity to various agents,6,16506052
0,22.0,Carbohydrate antigen 125 increased,6,16506053
1,22.0,Hot flush,6,16506053
2,22.0,Headache,6,16506053
3,22.0,Constipation,3,16506053
4,22.0,Fatigue,6,16506053
0,22.0,Product dose omission,6,16506061
0,22.0,Drug intolerance,6,16506063
1,22.0,Toxicity to various agents,6,16506063
0,22.0,Spinal pain,6,16506064
1,22.0,Asthenia,6,16506064
2,22.0,Crying,6,16506064
3,22.0,Adverse event,3,16506064
0,22.0,Drug intolerance,6,16506065
1,22.0,Toxicity to various agents,6,16506065
0,22.0,Abdominal discomfort,3,16506072
1,22.0,Platelet count decreased,3,16506072
2,22.0,Vomiting,1,16506072
0,22.0,Photosensitivity reaction,3,16506073
0,22.0,Malignant neoplasm progression,3,16506074
1,22.0,Drug ineffective,6,16506074
2,22.0,Product use in unapproved indication,6,16506074
0,22.0,Malignant neoplasm progression,6,16506075
1,22.0,Blood creatinine increased,6,16506075
0,22.0,Vomiting,2,16506076
1,22.0,Dysgeusia,1,16506076
2,22.0,Nausea,1,16506076
0,22.0,Toxicity to various agents,6,16506077
1,22.0,Drug intolerance,6,16506077
0,22.0,Feeling cold,6,16506078
1,22.0,Alopecia,6,16506078
0,22.1,Aspartate aminotransferase increased,3,16506079
1,22.1,Alanine aminotransferase increased,3,16506079
2,22.1,Photosensitivity reaction,2,16506079
3,22.1,Fatigue,3,16506079
4,22.1,White blood cell count decreased,6,16506079
5,22.1,Nausea,2,16506079
6,22.1,Red blood cell count decreased,6,16506079
0,22.0,Blood creatinine increased,6,16506081
1,22.0,Product use in unapproved indication,6,16506081
2,22.0,Glomerular filtration rate decreased,6,16506081
0,22.0,Product dose omission,6,16506082
1,22.0,Product use in unapproved indication,6,16506082
0,22.0,Drug intolerance,6,16506083
1,22.0,Toxicity to various agents,6,16506083
0,22.0,Blister,3,16506084
0,22.0,Toxicity to various agents,6,16506085
1,22.0,Drug intolerance,6,16506085
0,22.1,Haemoglobin decreased,6,16506086
1,22.1,Headache,1,16506086
2,22.1,Fatigue,3,16506086
3,22.1,Transfusion,3,16506086
0,22.0,Adverse event,3,16506087
1,22.0,Nausea,3,16506087
2,22.0,Fatigue,3,16506087
3,22.0,Product dose omission,6,16506087
0,22.0,Dyspnoea,6,16506104
0,22.0,Malignant neoplasm progression,3,16506106
1,22.0,Carbohydrate antigen 125 increased,3,16506106
0,22.0,Skin haemorrhage,3,16506107
1,22.0,Rash,3,16506107
2,22.0,Dry skin,3,16506107
3,22.0,Blood pressure decreased,3,16506107
0,22.0,Anaemia,6,16506108
1,22.0,Fatigue,6,16506108
2,22.0,Diarrhoea,6,16506108
3,22.0,Myalgia,6,16506108
0,22.0,Fatigue,1,16506109
1,22.0,Blood count abnormal,3,16506109
2,22.0,Vomiting,6,16506109
3,22.0,Transaminases increased,1,16506109
4,22.0,Neutropenia,1,16506109
5,22.0,Taste disorder,3,16506109
0,22.0,Vomiting,1,16506110
0,22.0,Toxicity to various agents,6,16506111
1,22.0,Drug intolerance,6,16506111
0,22.0,Malignant neoplasm progression,6,16506112
0,22.0,Drug intolerance,6,16506114
1,22.0,Toxicity to various agents,6,16506114
0,22.0,Decreased appetite,3,16506115
1,22.0,Nausea,3,16506115
2,22.0,Product dose omission,6,16506115
3,22.0,Taste disorder,3,16506115
0,22.0,Malignant neoplasm progression,6,16506116
0,22.0,Toxicity to various agents,6,16506117
1,22.0,Drug intolerance,6,16506117
0,22.0,Drug intolerance,6,16506118
1,22.0,Toxicity to various agents,6,16506118
0,22.0,Toxicity to various agents,6,16506119
1,22.0,Drug intolerance,6,16506119
0,22.0,Vomiting,6,16506122
1,22.0,Nausea,6,16506122
0,22.0,Drug intolerance,6,16506123
1,22.0,Toxicity to various agents,6,16506123
0,22.0,Nausea,1,16506124
1,22.0,Nausea,3,16506124
2,22.0,Muscular weakness,3,16506124
3,22.0,Diarrhoea,3,16506124
4,22.0,Fatigue,3,16506124
0,22.0,Nausea,6,16506125
1,22.0,Vomiting,6,16506125
2,22.0,Constipation,6,16506125
3,22.0,Anaemia,6,16506125
4,22.0,Malignant neoplasm progression,6,16506125
5,22.0,Diarrhoea,6,16506125
0,22.0,Abdominal pain,3,16506133
1,22.0,Abdominal pain upper,3,16506133
2,22.0,White blood cell count decreased,6,16506133
3,22.0,Abdominal distension,3,16506133
4,22.0,Platelet count decreased,6,16506133
5,22.0,Abdominal discomfort,3,16506133
0,22.0,Malignant neoplasm progression,6,16506134
0,22.0,Malignant neoplasm progression,3,16506143
1,22.0,Carbohydrate antigen 125 increased,3,16506143
0,22.1,Nausea,3,16506144
1,22.1,Fatigue,3,16506144
2,22.1,Constipation,3,16506144
0,22.0,Abdominal pain upper,1,16506145
1,22.0,Platelet count decreased,2,16506145
2,22.0,Vomiting,2,16506145
3,22.0,Cystitis,6,16506145
4,22.0,Food intolerance,2,16506145
5,22.0,Abdominal pain,3,16506145
6,22.0,Vomiting,1,16506145
7,22.0,Nausea,3,16506145
8,22.0,White blood cell count decreased,6,16506145
9,22.0,Adverse event,6,16506145
10,22.0,Rhinorrhoea,6,16506145
11,22.0,Regurgitation,3,16506145
12,22.0,Nausea,2,16506145
13,22.0,Abdominal discomfort,3,16506145
14,22.0,Haemoglobin decreased,6,16506145
15,22.0,Nodule,3,16506145
16,22.0,Carbohydrate antigen 125 increased,6,16506145
0,22.0,Fall,1,16506146
1,22.0,Feeling abnormal,2,16506146
2,22.0,Wound,2,16506146
3,22.0,Adverse event,6,16506146
4,22.0,Insomnia,6,16506146
0,22.0,Dry mouth,6,16506147
1,22.0,Carbohydrate antigen 125 increased,6,16506147
2,22.0,Nausea,3,16506147
3,22.0,Fatigue,3,16506147
4,22.0,Hepatic enzyme increased,6,16506147
5,22.0,Taste disorder,3,16506147
6,22.0,Platelet count decreased,6,16506147
7,22.0,Abdominal discomfort,3,16506147
0,22.1,Dizziness,6,16506148
1,22.1,Foreign body in respiratory tract,6,16506148
2,22.1,Fatigue,3,16506148
3,22.1,Accidental underdose,6,16506148
4,22.1,Tinnitus,6,16506148
5,22.1,Product dose omission,6,16506148
6,22.1,Throat irritation,6,16506148
0,22.0,Asthenia,3,16506149
1,22.0,Complication associated with device,6,16506149
2,22.0,Fatigue,6,16506149
3,22.0,Product use in unapproved indication,6,16506149
4,22.0,Vomiting,6,16506149
0,22.0,Pain,6,16506150
1,22.0,Dyspnoea,3,16506150
2,22.0,Fatigue,6,16506150
3,22.0,Taste disorder,6,16506150
4,22.0,Abdominal discomfort,6,16506150
0,22.0,Fatigue,3,16506151
1,22.0,Presyncope,3,16506151
0,22.0,Abdominal pain upper,3,16506152
1,22.0,Feeling abnormal,3,16506152
0,22.0,Adverse event,6,16506153
1,22.0,Somnolence,3,16506153
2,22.0,Malignant neoplasm progression,6,16506153
3,22.0,Fatigue,3,16506153
4,22.0,Product dose omission,6,16506153
0,22.0,Nausea,1,16506154
1,22.0,Fatigue,1,16506154
0,22.0,Depressed mood,3,16506156
1,22.0,Nausea,3,16506156
2,22.0,Disturbance in attention,3,16506156
3,22.0,Abdominal pain,3,16506156
4,22.0,Fatigue,3,16506156
5,22.0,Respiratory tract congestion,3,16506156
6,22.0,Anxiety,3,16506156
7,22.0,Diarrhoea,3,16506156
0,22.1,Hiccups,6,16506157
1,22.1,Peripheral swelling,1,16506157
2,22.1,Nausea,3,16506157
3,22.1,Diarrhoea,6,16506157
4,22.1,Abdominal pain upper,6,16506157
5,22.1,Product dose omission,6,16506157
6,22.1,Blood creatinine increased,3,16506157
7,22.1,Dysgeusia,6,16506157
8,22.1,White blood cell count decreased,6,16506157
9,22.1,Headache,3,16506157
10,22.1,Hypoaesthesia,2,16506157
11,22.1,Hepatic function abnormal,6,16506157
12,22.1,Peripheral swelling,6,16506157
0,22.0,Insomnia,3,16506158
1,22.0,Malignant neoplasm progression,3,16506158
2,22.0,Carbohydrate antigen 125 increased,3,16506158
0,22.0,Renal disorder,3,16506195
1,22.0,Laboratory test abnormal,6,16506195
2,22.0,Transfusion,6,16506195
3,22.0,Liver disorder,1,16506195
4,22.0,Malignant neoplasm progression,3,16506195
0,22.0,Rash pruritic,3,16506196
1,22.0,Hypoaesthesia,3,16506196
2,22.0,Liver function test increased,3,16506196
3,22.0,Multiple allergies,3,16506196
4,22.0,Nausea,3,16506196
5,22.0,Acne,3,16506196
6,22.0,Laboratory test abnormal,3,16506196
7,22.0,Peripheral swelling,3,16506196
8,22.0,Constipation,3,16506196
0,22.0,Paraesthesia,3,16506198
1,22.0,Pruritus,3,16506198
2,22.0,Product dose omission,6,16506198
3,22.0,Fatigue,3,16506198
4,22.0,Diarrhoea,3,16506198
5,22.0,Hypersensitivity,3,16506198
6,22.0,Headache,3,16506198
0,22.0,Lymphadenopathy,3,16506206
1,22.0,Feeding disorder,6,16506206
2,22.0,Fatigue,6,16506206
3,22.0,Blood magnesium decreased,3,16506206
4,22.0,Weight decreased,6,16506206
5,22.0,Diarrhoea,2,16506206
6,22.0,Nausea,6,16506206
0,22.0,Decreased appetite,2,16506207
1,22.0,Nausea,2,16506207
0,22.0,Chest pain,6,16506208
1,22.0,Upper respiratory tract infection,1,16506208
2,22.0,Intestinal obstruction,6,16506208
0,22.0,Gastric infection,1,16506209
1,22.0,Fatigue,1,16506209
2,22.0,Diarrhoea,1,16506209
3,22.0,Nausea,1,16506209
0,22.0,Rash,1,16506210
0,22.1,Abdominal pain,3,16506211
1,22.1,Photosensitivity reaction,3,16506211
2,22.1,Sunburn,3,16506211
3,22.1,Temperature intolerance,3,16506211
4,22.1,Alopecia,3,16506211
5,22.1,Fatigue,3,16506211
0,22.0,Malaise,3,16506212
1,22.0,Feeling abnormal,3,16506212
2,22.0,Blood cholesterol increased,3,16506212
3,22.0,Asthenia,6,16506212
4,22.0,Alanine aminotransferase increased,3,16506212
5,22.0,Depression,3,16506212
6,22.0,Constipation,3,16506212
7,22.0,Fatigue,3,16506212
8,22.0,Blood triglycerides increased,3,16506212
9,22.0,Blood alkaline phosphatase increased,3,16506212
10,22.0,Nausea,3,16506212
11,22.0,Abdominal discomfort,3,16506212
12,22.0,Liver function test increased,6,16506212
13,22.0,Aspartate aminotransferase increased,3,16506212
14,22.0,Photosensitivity reaction,6,16506212
0,22.0,Paraesthesia,6,16506213
1,22.0,Dysgeusia,6,16506213
2,22.0,Haemoglobin decreased,6,16506213
3,22.0,Erythema,6,16506213
4,22.0,Sunburn,6,16506213
5,22.0,Fall,6,16506213
6,22.0,Laboratory test abnormal,6,16506213
0,22.0,Fatigue,2,16506214
1,22.0,Dizziness,6,16506214
2,22.0,Nausea,2,16506214
3,22.0,Platelet count decreased,3,16506214
4,22.0,Diarrhoea,6,16506214
5,22.0,Dyspepsia,3,16506214
6,22.0,DNA mismatch repair protein gene mutation,6,16506214
0,22.0,Nausea,3,16506215
1,22.0,Constipation,3,16506215
2,22.0,Feeling abnormal,6,16506215
3,22.0,Dyspepsia,6,16506215
4,22.0,Abdominal discomfort,6,16506215
5,22.0,Hot flush,6,16506215
6,22.0,Chills,6,16506215
7,22.0,Fatigue,6,16506215
8,22.0,Diarrhoea,3,16506215
0,22.1,Nasopharyngitis,6,16506216
1,22.1,Dry eye,6,16506216
2,22.1,Hypersensitivity,3,16506216
3,22.1,Mucosal dryness,3,16506216
4,22.1,Lower respiratory tract infection,6,16506216
0,22.0,Drug intolerance,6,16506217
1,22.0,Toxicity to various agents,6,16506217
0,22.0,Laboratory test abnormal,6,16506219
1,22.0,Product use in unapproved indication,6,16506219
2,22.0,Fatigue,6,16506219
3,22.0,Product dose omission,6,16506219
0,22.0,Dysgeusia,3,16506220
0,22.0,Nasopharyngitis,3,16506221
0,22.0,Drug intolerance,6,16506223
1,22.0,Anaemia,6,16506223
2,22.0,Fatigue,6,16506223
0,22.0,Drug intolerance,6,16506224
1,22.0,Toxicity to various agents,6,16506224
0,22.0,Dry mouth,6,16506225
1,22.0,Fatigue,2,16506225
2,22.0,Fatigue,1,16506225
3,22.0,Taste disorder,6,16506225
0,22.1,Pallor,6,16506227
1,22.1,Taste disorder,3,16506227
2,22.1,Constipation,3,16506227
3,22.1,Weight decreased,3,16506227
4,22.1,Decreased appetite,3,16506227
5,22.1,Dizziness,2,16506227
6,22.1,Haemorrhage,6,16506227
7,22.1,Gait disturbance,6,16506227
8,22.1,Fatigue,3,16506227
9,22.1,Vomiting,1,16506227
10,22.1,Dyspnoea,6,16506227
11,22.1,Heart rate increased,6,16506227
12,22.1,Asthenia,2,16506227
13,22.1,Vomiting,6,16506227
14,22.1,Alopecia,6,16506227
15,22.1,Sleep deficit,6,16506227
0,22.0,Haematuria,3,16506228
1,22.0,Fatigue,6,16506228
2,22.0,Constipation,3,16506228
3,22.0,Creatinine urine increased,1,16506228
4,22.0,Decreased appetite,6,16506228
5,22.0,Abdominal distension,3,16506228
6,22.0,Malignant neoplasm progression,3,16506228
0,22.0,Back pain,6,16506244
1,22.0,Malignant neoplasm progression,6,16506244
2,22.0,Drug ineffective,6,16506244
3,22.0,Tumour marker increased,6,16506244
4,22.0,Fatigue,3,16506244
0,22.0,Laboratory test abnormal,6,16506245
1,22.0,Abdominal pain,6,16506245
2,22.0,Product dose omission,6,16506245
3,22.0,Frequent bowel movements,6,16506245
4,22.0,Carbohydrate antigen 125 increased,6,16506245
5,22.0,Taste disorder,6,16506245
6,22.0,Fatigue,3,16506245
7,22.0,Blood potassium decreased,6,16506245
8,22.0,Drug ineffective,6,16506245
9,22.0,Insomnia,6,16506245
0,22.0,Malignant neoplasm progression,6,16506246
0,22.1,Flatulence,6,16506247
1,22.1,Muscle strain,6,16506247
2,22.1,Nausea,3,16506247
3,22.1,Anaemia,1,16506247
0,22.0,Pruritus,1,16506248
0,22.0,Nausea,3,16506249
1,22.0,Pruritus,3,16506249
2,22.0,Fatigue,3,16506249
3,22.0,Dyspnoea exertional,3,16506249
4,22.0,Asthenia,3,16506249
0,22.0,Spondylitis,3,16506250
0,22.0,Accidental underdose,6,16506251
1,22.0,Dizziness,3,16506251
2,22.0,Nausea,3,16506251
3,22.0,Motion sickness,6,16506251
4,22.0,Stomatitis,3,16506251
5,22.0,Blood count abnormal,6,16506251
6,22.0,Platelet count decreased,6,16506251
0,22.0,Dysphagia,3,16506252
1,22.0,Product use complaint,6,16506252
0,22.0,Dyspnoea,6,16506253
1,22.0,Pain in extremity,3,16506253
2,22.0,Nausea,6,16506253
3,22.0,Diarrhoea,6,16506253
4,22.0,Productive cough,3,16506253
5,22.0,Abdominal discomfort,6,16506253
6,22.0,Constipation,6,16506253
7,22.0,Abdominal pain upper,6,16506253
8,22.0,Fatigue,3,16506253
9,22.0,Pruritus generalised,3,16506253
0,22.1,Breast pain,3,16506254
1,22.1,Asthenia,3,16506254
2,22.1,Constipation,2,16506254
3,22.1,Abdominal pain,3,16506254
4,22.1,Product use complaint,6,16506254
5,22.1,Discoloured vomit,3,16506254
6,22.1,Malaise,3,16506254
7,22.1,Nausea,2,16506254
8,22.1,Vomiting,6,16506254
0,22.0,Haemoglobin decreased,6,16506255
0,22.0,Fatigue,6,16506256
1,22.0,Malignant neoplasm progression,6,16506256
0,22.1,Nausea,6,16506257
1,22.1,Abdominal pain,2,16506257
2,22.1,Oral pain,6,16506257
3,22.1,Drug ineffective,6,16506257
4,22.1,Diarrhoea,1,16506257
5,22.1,Fatigue,3,16506257
6,22.1,Diarrhoea,2,16506257
0,22.0,Constipation,1,16506258
1,22.0,Fatigue,3,16506258
2,22.0,Back pain,6,16506258
3,22.0,Taste disorder,6,16506258
4,22.0,Dysphagia,6,16506258
5,22.0,Erythema,6,16506258
6,22.0,Product dose omission,6,16506258
7,22.0,Flushing,6,16506258
8,22.0,Pruritus,6,16506258
0,22.0,Oedema peripheral,3,16506262
1,22.0,Nausea,3,16506262
0,22.0,Nausea,6,16506263
1,22.0,Asthenia,2,16506263
2,22.0,Taste disorder,2,16506263
3,22.0,Crying,2,16506263
4,22.0,Headache,2,16506263
5,22.0,Fatigue,2,16506263
6,22.0,Decreased appetite,2,16506263
7,22.0,Abdominal pain,6,16506263
8,22.0,Pain in extremity,2,16506263
9,22.0,Diarrhoea,6,16506263
10,22.0,Vomiting,6,16506263
11,22.0,Depressed mood,2,16506263
12,22.0,Constipation,2,16506263
0,22.0,Ovarian cancer recurrent,6,16506264
0,22.0,Somnolence,6,16506284
0,22.0,Loss of personal independence in daily activities,3,16506285
1,22.0,Fatigue,3,16506285
0,22.0,Feeling abnormal,6,16506286
1,22.0,Asthenia,6,16506286
2,22.0,Platelet count decreased,2,16506286
0,22.0,Nervous system disorder,6,16506287
1,22.0,Eye pain,6,16506287
2,22.0,Headache,6,16506287
3,22.0,Cardiac disorder,6,16506287
4,22.0,Heart rate increased,6,16506287
5,22.0,Eye disorder,6,16506287
0,22.0,Fatigue,6,16506288
1,22.0,Nausea,6,16506288
0,22.0,Product use in unapproved indication,6,16506289
1,22.0,Product dose omission,6,16506289
0,22.0,Drug intolerance,6,16506290
1,22.0,Dizziness,6,16506290
2,22.0,Nausea,3,16506290
3,22.0,Rhinorrhoea,3,16506290
4,22.0,Blister,3,16506290
5,22.0,Pyrexia,3,16506290
6,22.0,Influenza like illness,3,16506290
7,22.0,Decreased appetite,6,16506290
0,22.0,Taste disorder,3,16506291
1,22.0,Asthenia,3,16506291
2,22.0,Anaemia,3,16506291
3,22.0,Diarrhoea,3,16506291
4,22.0,Nausea,2,16506291
5,22.0,Abdominal pain upper,3,16506291
6,22.0,Serum ferritin increased,3,16506291
7,22.0,Arthralgia,3,16506291
8,22.0,Fatigue,2,16506291
0,22.0,Abdominal discomfort,3,16506292
1,22.0,Fatigue,3,16506292
0,22.0,Taste disorder,6,16506293
1,22.0,Hepatic enzyme increased,2,16506293
2,22.0,Malignant neoplasm progression,6,16506293
3,22.0,Abdominal distension,6,16506293
4,22.0,Fatigue,3,16506293
5,22.0,Nausea,1,16506293
6,22.0,Parosmia,6,16506293
7,22.0,Product dose omission,6,16506293
8,22.0,Constipation,3,16506293
9,22.0,Abdominal pain upper,6,16506293
0,22.0,Bleeding time prolonged,1,16506294
1,22.0,Pain,1,16506294
2,22.0,Vomiting,1,16506294
3,22.0,Taste disorder,1,16506294
0,22.1,Blood creatinine increased,6,16506295
1,22.1,Fatigue,3,16506295
2,22.1,Anaemia,3,16506295
0,22.1,Cough,1,16506301
1,22.1,Malaise,6,16506301
2,22.1,Ageusia,6,16506301
3,22.1,Nausea,3,16506301
4,22.1,Mycobacterium avium complex infection,2,16506301
5,22.1,Tumour marker increased,2,16506301
6,22.1,Hepatic enzyme increased,6,16506301
7,22.1,Chills,6,16506301
8,22.1,Dysphonia,3,16506301
9,22.1,Joint swelling,6,16506301
10,22.1,Respiratory tract infection,2,16506301
11,22.1,Weight decreased,6,16506301
12,22.1,Night sweats,1,16506301
13,22.1,Productive cough,2,16506301
14,22.1,Chest discomfort,3,16506301
15,22.1,Balance disorder,6,16506301
16,22.1,Abdominal distension,6,16506301
17,22.1,Dysgeusia,3,16506301
18,22.1,Hypoglycaemia,6,16506301
19,22.1,Taste disorder,3,16506301
20,22.1,Dyspnoea,1,16506301
21,22.1,Diarrhoea,6,16506301
22,22.1,Stress,6,16506301
23,22.1,Night sweats,6,16506301
24,22.1,Appetite disorder,6,16506301
25,22.1,Carbohydrate antigen 125 increased,3,16506301
26,22.1,Peripheral swelling,6,16506301
27,22.1,Product dose omission,6,16506301
28,22.1,Adverse event,6,16506301
29,22.1,Sputum discoloured,3,16506301
30,22.1,Alopecia,6,16506301
31,22.1,Fatigue,2,16506301
0,22.1,Hepatic enzyme increased,3,16506302
1,22.1,Nausea,3,16506302
2,22.1,Decreased appetite,3,16506302
3,22.1,Taste disorder,3,16506302
4,22.1,Fatigue,3,16506302
0,22.0,Drug intolerance,6,16506313
1,22.0,Toxicity to various agents,6,16506313
0,22.0,Drug intolerance,6,16506314
1,22.0,Toxicity to various agents,6,16506314
0,22.0,Vomiting,6,16506315
1,22.0,Nausea,6,16506315
0,22.0,Toxicity to various agents,6,16506316
1,22.0,Drug intolerance,6,16506316
0,22.0,Toxicity to various agents,6,16506317
1,22.0,Drug intolerance,6,16506317
0,22.0,Drug intolerance,6,16506318
1,22.0,Toxicity to various agents,6,16506318
0,22.0,Nausea,3,16506319
1,22.0,Diarrhoea,3,16506319
0,22.0,Toxicity to various agents,6,16506320
1,22.0,Drug intolerance,6,16506320
0,22.0,Drug intolerance,6,16506321
1,22.0,Toxicity to various agents,6,16506321
0,22.0,Drug intolerance,6,16506324
1,22.0,Toxicity to various agents,6,16506324
0,22.0,Toxicity to various agents,6,16506326
1,22.0,Drug intolerance,6,16506326
0,22.0,Drug intolerance,6,16506327
1,22.0,Toxicity to various agents,6,16506327
0,22.0,Toxicity to various agents,6,16506328
1,22.0,Drug intolerance,6,16506328
0,22.0,Drug intolerance,6,16506329
1,22.0,Toxicity to various agents,6,16506329
0,22.0,Toxicity to various agents,6,16506330
1,22.0,Drug intolerance,6,16506330
0,22.0,Colorectal cancer,,16506494
0,22.0,Cardiac failure,4,16506497
1,22.0,Multiple organ dysfunction syndrome,4,16506497
2,22.0,Cardiogenic shock,4,16506497
0,22.1,Neuropathy peripheral,3,16506564
1,22.1,Insomnia,2,16506564
2,22.1,Atrial fibrillation,6,16506564
3,22.1,Dry mouth,6,16506564
4,22.1,Full blood count decreased,6,16506564
5,22.1,Platelet count decreased,3,16506564
6,22.1,Inappropriate schedule of product administration,1,16506564
7,22.1,Nausea,6,16506564
8,22.1,Fatigue,3,16506564
0,22.0,Pneumocystis jirovecii pneumonia,1,16506636
0,22.0,Drug resistance,6,16506653
1,22.0,Back pain,6,16506653
2,22.0,Pain in extremity,6,16506653
3,22.0,Malignant neoplasm progression,2,16506653
4,22.0,Abdominal pain,6,16506653
5,22.0,Constipation,6,16506653
0,22.0,Death,5,16506689
0,22.1,Thrombocytopenia,1,16506759
1,22.1,Anaemia,1,16506759
2,22.1,Neutropenia,1,16506759
3,22.1,Drug intolerance,6,16506759
4,22.1,Disease progression,3,16506759
5,22.1,Nausea,6,16506759
0,22.0,Haematotoxicity,6,16506784
1,22.0,Pancytopenia,6,16506784
2,22.0,Neutropenia,6,16506784
3,22.0,Off label use,6,16506784
0,22.0,Renal cancer,1,16506808
0,22.0,Bone marrow failure,1,16506844
0,22.0,Bone marrow failure,1,16506845
0,22.0,General physical health deterioration,6,16506869
1,22.0,Vomiting,1,16506869
2,22.0,Hyponatraemia,6,16506869
3,22.0,Mucosal inflammation,1,16506869
4,22.0,Asthenia,1,16506869
5,22.0,Diarrhoea,1,16506869
0,22.0,Pneumonitis,5,16506973
0,22.0,Febrile neutropenia,5,16506974
0,22.0,Febrile neutropenia,5,16506975
0,22.0,Pancytopenia,1,16506976
1,22.0,Visceral leishmaniasis,1,16506976
0,22.0,Febrile neutropenia,5,16506981
0,22.0,Pain in extremity,2,16507035
1,22.0,Lymphoedema,3,16507035
2,22.0,Hot flush,4,16507035
0,22.1,Adrenal insufficiency,2,16507219
1,22.1,Cardiac tamponade,1,16507219
0,22.0,Rash,1,16507278
1,22.0,Tremor,1,16507278
2,22.0,Oxygen saturation decreased,1,16507278
0,22.1,Hair disorder,3,16507367
1,22.1,Madarosis,3,16507367
2,22.1,Alopecia,3,16507367
3,22.1,Hair texture abnormal,3,16507367
4,22.1,Hair colour changes,3,16507367
0,22.1,Platelet count decreased,5,16507468
1,22.1,Hepatic function abnormal,3,16507468
2,22.1,Acute myeloid leukaemia,5,16507468
3,22.1,Anaemia,1,16507468
0,22.0,Death,5,16507471
1,22.0,Dyspnoea exertional,6,16507471
2,22.0,Weight decreased,6,16507471
3,22.0,Urinary tract infection,6,16507471
4,22.0,Back pain,6,16507471
5,22.0,Dysgeusia,6,16507471
6,22.0,Asthenia,6,16507471
7,22.0,Decreased appetite,6,16507471
0,22.0,Bone marrow failure,6,16507607
0,22.0,Ascites,6,16507614
1,22.0,Condition aggravated,6,16507614
2,22.0,Deep vein thrombosis,6,16507614
3,22.0,Neuropathy peripheral,6,16507614
0,22.0,Confusional state,1,16507616
1,22.0,Poverty of speech,1,16507616
0,22.0,Intentional product use issue,6,16507623
1,22.0,Off label use,6,16507623
2,22.0,Metastases to peritoneum,6,16507623
0,22.1,Small intestinal haemorrhage,5,16507631
1,22.1,Aortic aneurysm rupture,5,16507631
0,22.0,Hypersensitivity pneumonitis,6,16507635
1,22.0,Tachycardia,6,16507635
2,22.0,Hyperthermia,6,16507635
3,22.0,Dyspnoea,6,16507635
0,22.0,General physical health deterioration,6,16507638
1,22.0,Asthenia,6,16507638
2,22.0,Hydroureter,6,16507638
3,22.0,Hydronephrosis,6,16507638
4,22.0,Formication,6,16507638
5,22.0,Haemoglobin decreased,6,16507638
6,22.0,Dyspepsia,6,16507638
7,22.0,Prostate cancer,6,16507638
8,22.0,Musculoskeletal stiffness,6,16507638
9,22.0,Cutaneous calcification,6,16507638
0,22.0,Intentional product use issue,6,16507639
1,22.0,Death,5,16507639
0,22.0,Off label use,6,16507646
1,22.0,Death,5,16507646
0,22.0,Extravasation,2,16507734
0,22.0,Drug resistance,6,16507759
1,22.0,Malignant neoplasm progression,6,16507759
0,22.0,Anastomotic leak,6,16507809
0,22.0,Granulocyte count decreased,6,16507837
1,22.0,Mucosal inflammation,6,16507837
2,22.0,Pigmentation disorder,1,16507837
3,22.0,Liver injury,6,16507837
4,22.0,Pruritus,1,16507837
5,22.0,Vomiting,6,16507837
6,22.0,Diarrhoea,6,16507837
7,22.0,Skin exfoliation,1,16507837
8,22.0,Nausea,6,16507837
9,22.0,Anaemia,6,16507837
10,22.0,Skin reaction,1,16507837
11,22.0,Platelet count decreased,6,16507837
0,22.0,Thrombosis,6,16507879
1,22.0,Cellulitis,1,16507879
2,22.0,Erythema,6,16507879
3,22.0,Tachycardia,6,16507879
4,22.0,Pyrexia,6,16507879
0,22.1,Abdominal pain,1,16507903
1,22.1,Gingivitis,1,16507903
2,22.1,Anaemia,1,16507903
0,22.0,Hair disorder,3,16507951
1,22.0,Hair texture abnormal,3,16507951
2,22.0,Hair colour changes,3,16507951
3,22.0,Alopecia,3,16507951
4,22.0,Madarosis,3,16507951
0,22.0,Rectal haemorrhage,6,16507958
1,22.0,Pulmonary thrombosis,6,16507958
2,22.0,Decreased appetite,3,16507958
3,22.0,Infusion related reaction,6,16507958
4,22.0,Tremor,3,16507958
5,22.0,Heart rate increased,3,16507958
6,22.0,Colitis,3,16507958
7,22.0,Clostridium difficile colitis,3,16507958
8,22.0,Asthenia,3,16507958
0,22.0,Malignant neoplasm progression,5,16507978
1,22.0,Cerebral infarction,6,16507978
0,22.1,Myelodysplastic syndrome,2,16508039
1,22.1,Constipation,1,16508039
2,22.1,Pneumonia,1,16508039
3,22.1,Upper respiratory tract inflammation,1,16508039
0,22.0,Product dose omission,6,16508044
1,22.0,Product availability issue,6,16508044
2,22.0,Anxiety,6,16508044
3,22.0,Blood pressure increased,6,16508044
0,22.0,Anaemia,2,16508062
1,22.0,Bone marrow toxicity,2,16508062
0,22.0,Anaemia,3,16508063
1,22.0,Refractory cytopenia with unilineage dysplasia,6,16508063
0,22.1,Disease progression,3,16508092
1,22.1,Colon cancer,3,16508092
0,22.0,Somnolence,3,16508101
1,22.0,Blister,6,16508101
2,22.0,Dry skin,6,16508101
3,22.0,Burning sensation,6,16508101
4,22.0,Depression,3,16508101
5,22.0,Sleep attacks,1,16508101
0,22.0,No adverse event,6,16508102
1,22.0,Incorrect dose administered,6,16508102
0,22.0,Drug ineffective,6,16508107
1,22.0,No adverse event,6,16508107
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,3,16508115
0,22.0,Pulmonary mass,3,16508119
1,22.0,Therapeutic response decreased,6,16508119
0,22.0,Peripheral swelling,6,16508120
1,22.0,Intentional product use issue,6,16508120
2,22.0,Off label use,6,16508120
3,22.0,Pain in extremity,6,16508120
0,22.0,Constipation,6,16508134
1,22.0,Pain,1,16508134
0,22.0,Nausea,6,16508136
1,22.0,Chromaturia,6,16508136
2,22.0,Vomiting,6,16508136
0,22.0,Erythema,6,16508140
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16508140
2,22.0,Gait disturbance,6,16508140
3,22.0,Skin exfoliation,6,16508140
4,22.0,Muscular weakness,6,16508140
5,22.0,Tooth fracture,6,16508140
6,22.0,Tooth abscess,3,16508140
7,22.0,Diarrhoea,6,16508140
8,22.0,Blister,6,16508140
9,22.0,Skin disorder,6,16508140
10,22.0,Fatigue,6,16508140
0,22.0,Diarrhoea,6,16508141
0,22.0,Rash,6,16508144
0,22.0,No adverse event,6,16508145
1,22.0,Drug ineffective,6,16508145
0,22.0,Epistaxis,6,16508155
1,22.0,Stomatitis,6,16508155
2,22.0,Gastrointestinal haemorrhage,6,16508155
0,22.0,Cellulitis,6,16508158
0,22.0,Decreased appetite,6,16508171
1,22.0,Fatigue,6,16508171
0,22.0,Dizziness,6,16508176
1,22.0,Off label use,6,16508176
2,22.0,Vomiting,6,16508176
3,22.0,Intentional product use issue,6,16508176
0,22.0,Off label use,6,16508191
1,22.0,Intentional product use issue,6,16508191
2,22.0,Vomiting,6,16508191
0,22.0,Hepatic lesion,6,16508194
1,22.0,Pulmonary mass,6,16508194
2,22.0,Mouth ulceration,6,16508194
0,22.0,Diarrhoea,6,16508198
0,22.0,No adverse event,6,16508223
1,22.0,Drug ineffective,6,16508223
0,22.0,Product dose omission,6,16508226
1,22.0,No adverse event,6,16508226
0,22.0,Infection,6,16508227
0,22.0,Diarrhoea,6,16508230
1,22.0,Abdominal discomfort,6,16508230
0,22.0,Paraesthesia,6,16508236
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16508238
1,22.0,Stomatitis,6,16508238
2,22.0,Dehydration,6,16508238
3,22.0,Hepatic neoplasm,6,16508238
4,22.0,Fluid retention,6,16508238
5,22.0,Vaginal ulceration,6,16508238
6,22.0,Weight increased,6,16508238
0,22.0,Inflammatory marker increased,2,16508252
1,22.0,White blood cell count decreased,2,16508252
0,22.0,Fatigue,6,16508255
0,22.0,Nausea,1,16508259
1,22.0,Memory impairment,6,16508259
0,22.0,Dehydration,6,16508274
1,22.0,Diarrhoea,2,16508274
2,22.0,Pain in extremity,6,16508274
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,1,16508275
0,22.0,Nausea,6,16508278
0,22.0,Hyperbilirubinaemia,6,16508279
0,22.0,Eye swelling,6,16508294
1,22.0,Swelling face,6,16508294
2,22.0,Pain in extremity,6,16508294
3,22.0,Back pain,6,16508294
4,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16508294
0,22.0,Dry skin,6,16508296
1,22.0,Skin exfoliation,6,16508296
0,22.0,Abdominal discomfort,6,16508303
1,22.0,Constipation,6,16508303
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16508306
1,22.0,Pain in extremity,6,16508306
0,22.0,Abdominal pain,6,16508309
0,22.0,Dry skin,6,16508313
0,22.0,Asthenia,6,16508314
1,22.0,Dehydration,6,16508314
0,22.0,Burning sensation,6,16508328
1,22.0,Peripheral swelling,6,16508328
2,22.0,Erythema,6,16508328
0,22.0,Fatigue,6,16508334
0,22.0,Ill-defined disorder,6,16508340
0,22.0,Nausea,6,16508341
1,22.0,Fatigue,6,16508341
2,22.0,Diarrhoea,6,16508341
3,22.0,Burning sensation,6,16508341
0,22.0,Pain,6,16508343
1,22.0,Dry skin,6,16508343
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16508343
0,22.0,Nasopharyngitis,6,16508357
0,22.0,Infection,6,16508362
0,22.0,Hand-foot-and-mouth disease,6,16508363
0,22.0,Fluid intake reduced,6,16508369
0,22.0,Vaginal ulceration,6,16508381
0,22.0,Diarrhoea,6,16508404
0,22.0,No adverse event,6,16508411
1,22.0,Off label use,6,16508411
2,22.0,Intentional product use issue,6,16508411
0,22.0,Insomnia,6,16508414
0,22.0,Vertebral lesion,6,16508422
1,22.0,Angina bullosa haemorrhagica,6,16508422
2,22.0,Retinal haemorrhage,6,16508422
3,22.0,Therapeutic product effect decreased,6,16508422
0,22.0,Renal failure,6,16508425
1,22.0,Diarrhoea,6,16508425
0,22.0,Hypertriglyceridaemia,2,16508432
0,22.0,Neutropenia,3,16508435
0,22.0,Flatulence,6,16508438
0,22.0,Haemorrhoids,6,16508439
1,22.0,Proctalgia,6,16508439
2,22.0,Anorectal disorder,6,16508439
3,22.0,Constipation,6,16508439
4,22.0,Hypertension,6,16508439
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16508440
0,22.0,Gout,6,16508441
1,22.0,Blood uric acid increased,6,16508441
2,22.0,Blood urea increased,6,16508441
3,22.0,Blood creatinine increased,6,16508441
0,22.0,Irritability,1,16508449
1,22.0,Mood swings,1,16508449
2,22.0,Anxiety,6,16508449
3,22.0,Insomnia,1,16508449
4,22.0,Depression,6,16508449
0,22.0,Alopecia,1,16508450
0,22.0,Rash,6,16508454
1,22.0,Ill-defined disorder,6,16508454
2,22.0,Pruritus,6,16508454
0,22.0,Fatigue,2,16508467
1,22.0,Cytopenia,6,16508467
2,22.0,Alopecia,2,16508467
3,22.0,Palmar-plantar erythrodysaesthesia syndrome,2,16508467
4,22.0,Stomatitis,2,16508467
0,22.0,Cardiac disorder,3,16508469
1,22.0,Product dose omission,6,16508469
0,22.0,Product dose omission,6,16508502
1,22.0,No adverse event,6,16508502
0,22.0,Ill-defined disorder,6,16508504
1,22.0,Myalgia,6,16508504
0,22.0,Dry skin,6,16508515
0,22.0,No adverse event,6,16508520
1,22.0,Drug ineffective,6,16508520
0,22.0,Decreased appetite,3,16508530
1,22.0,Fatigue,3,16508530
2,22.0,Nausea,3,16508530
3,22.0,Anxiety,3,16508530
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,3,16508536
1,22.0,Fatigue,3,16508536
0,22.0,Diarrhoea,6,16508538
1,22.0,Stomatitis,6,16508538
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16508538
0,22.0,Malaise,6,16508539
0,22.0,Infection,6,16508546
0,22.0,Diarrhoea,3,16508564
0,22.1,Adenocarcinoma,5,16508565
0,22.0,Stomatitis,2,16508566
0,22.0,Fatigue,3,16508568
1,22.0,Therapeutic product effect decreased,6,16508568
0,22.0,Constipation,6,16508569
1,22.0,Asthenia,6,16508569
0,22.0,Diarrhoea,6,16508574
1,22.0,Abdominal pain upper,6,16508574
0,22.0,Paraesthesia,6,16508584
1,22.0,Mouth swelling,6,16508584
2,22.0,White blood cell count increased,6,16508584
0,22.0,Dry skin,1,16508586
1,22.0,Burning sensation,1,16508586
0,22.0,Intentional product use issue,6,16508589
1,22.0,No adverse event,6,16508589
2,22.0,Off label use,6,16508589
0,22.0,Acute myocardial infarction,1,16508600
0,22.0,Vomiting,6,16508603
1,22.0,Nausea,6,16508603
2,22.0,Pain,6,16508603
0,22.0,Onychalgia,6,16508608
1,22.0,Skin discolouration,6,16508608
2,22.0,Nail discolouration,6,16508608
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16508618
1,22.0,Diarrhoea,6,16508618
2,22.0,Stomatitis,6,16508618
0,22.0,Nausea,3,16508632
0,22.0,Alopecia,6,16508654
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16508654
0,22.0,Drug ineffective,6,16508674
1,22.0,No adverse event,6,16508674
0,22.0,Diarrhoea,6,16508679
0,22.0,Paraesthesia,6,16508680
1,22.0,Neuropathy peripheral,6,16508680
0,22.0,Herpes zoster,6,16508687
0,22.0,Drug ineffective,6,16508704
1,22.0,No adverse event,6,16508704
0,22.0,Urinary tract infection,6,16508707
0,22.0,Actinic keratosis,3,16508708
0,22.0,Intentional product use issue,6,16508713
1,22.0,No adverse event,6,16508713
2,22.0,Off label use,6,16508713
0,22.0,Intentional product use issue,6,16508715
1,22.0,Vertigo,3,16508715
2,22.0,Off label use,6,16508715
0,22.0,Intentional product use issue,6,16508717
1,22.0,No adverse event,6,16508717
2,22.0,Off label use,6,16508717
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,2,16508724
1,22.0,Oral pigmentation,2,16508724
2,22.0,Skin hyperpigmentation,2,16508724
0,22.0,Mucosal inflammation,2,16508725
1,22.0,Dehydration,1,16508725
2,22.0,Headache,6,16508725
3,22.0,Diarrhoea,2,16508725
4,22.0,Vomiting,1,16508725
5,22.0,Chest pain,1,16508725
0,22.0,Blister,2,16508727
1,22.0,Skin exfoliation,2,16508727
2,22.0,Swelling,2,16508727
3,22.0,Lacrimation increased,6,16508727
4,22.0,Rhinorrhoea,3,16508727
5,22.0,Pain,3,16508727
0,22.0,Hypertriglyceridaemia,2,16508732
0,22.0,Hypertriglyceridaemia,2,16508739
0,22.0,Dysuria,6,16508740
1,22.0,Back pain,6,16508740
2,22.0,Product dose omission,6,16508740
0,22.0,Arthralgia,3,16508742
0,22.0,Liver function test increased,6,16508748
0,22.0,Eye discharge,6,16508755
1,22.0,Scab,6,16508755
2,22.0,Gait disturbance,6,16508755
3,22.0,Lacrimation increased,6,16508755
4,22.0,Oral mucosal blistering,2,16508755
5,22.0,Nail discolouration,2,16508755
6,22.0,Nausea,6,16508755
7,22.0,Fatigue,6,16508755
0,22.0,Therapeutic response decreased,6,16508757
0,22.0,Diarrhoea,6,16508764
0,22.0,Fingerprint loss,3,16508773
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16508773
0,22.0,Intentional product use issue,6,16508809
1,22.0,Product packaging quantity issue,6,16508809
2,22.0,Off label use,6,16508809
3,22.0,No adverse event,6,16508809
0,22.0,Neuropathy peripheral,3,16508810
0,22.0,Nausea,1,16508821
1,22.0,Vomiting,1,16508821
0,22.0,Pancytopenia,1,16508823
1,22.0,Urinary tract infection,1,16508823
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,1,16508823
3,22.0,Mucosal inflammation,1,16508823
4,22.0,Renal failure,1,16508823
5,22.0,Febrile neutropenia,1,16508823
0,22.0,Blood count abnormal,6,16508831
0,22.0,Burning sensation,3,16508840
1,22.0,Gait disturbance,3,16508840
2,22.0,Pruritus,3,16508840
3,22.0,Pain,3,16508840
4,22.0,Oral mucosal blistering,3,16508840
5,22.0,Lethargy,3,16508840
0,22.0,Drug ineffective,6,16508842
1,22.0,No adverse event,6,16508842
0,22.1,Hypoxia,1,16508894
1,22.1,Malaise,1,16508894
2,22.1,Blood pressure decreased,1,16508894
3,22.1,Tremor,1,16508894
4,22.1,Chills,1,16508894
0,22.0,Back pain,2,16508940
1,22.0,Suffocation feeling,2,16508940
0,22.0,Bronchospasm,1,16509061
0,22.0,Diarrhoea,6,16509068
1,22.0,Pneumonitis,6,16509068
2,22.0,Vomiting,6,16509068
0,22.0,Hypoaesthesia,6,16509158
1,22.0,Off label use,6,16509158
2,22.0,Odynophagia,3,16509158
3,22.0,Palpitations,6,16509158
4,22.0,Decreased appetite,3,16509158
0,22.0,Angioedema,,16509194
1,22.0,Stridor,,16509194
2,22.0,Swelling face,,16509194
3,22.0,Injection site urticaria,,16509194
0,22.0,Mucosal inflammation,5,16509213
1,22.0,Shock,5,16509213
2,22.0,Dehydration,5,16509213
3,22.0,Diarrhoea,5,16509213
0,22.0,Cerebrovascular accident,6,16509214
0,22.0,Venous thrombosis limb,6,16509280
1,22.0,Anaemia,6,16509280
2,22.0,Pulmonary embolism,6,16509280
0,22.0,Leukopenia,6,16509282
1,22.0,Off label use,6,16509282
2,22.0,Neutropenia,6,16509282
0,22.0,Bone marrow failure,2,16509427
0,22.0,Hepatic cancer,,16509479
1,22.0,Procedural pain,,16509479
2,22.0,Constipation,,16509479
0,22.0,Rectal polyp,6,16509563
0,22.0,Intestinal perforation,3,16509565
0,22.0,Aortic thrombosis,3,16509583
0,22.0,Death,5,16509607
1,22.0,Fatigue,6,16509607
0,22.0,Prescribed underdose,6,16509653
1,22.0,Disseminated intravascular coagulation,1,16509653
2,22.0,Off label use,6,16509653
3,22.0,Acute hepatic failure,1,16509653
0,22.0,Fatigue,,16509668
0,22.0,Thyrotoxic crisis,5,16509719
1,22.0,Basedow^s disease,6,16509719
2,22.0,Cardiac failure,5,16509719
0,22.0,International normalised ratio increased,3,16509720
0,22.0,Rash,2,16509790
1,22.0,Somnolence,3,16509790
2,22.0,Nausea,2,16509790
3,22.0,Off label use,6,16509790
4,22.0,Vertigo,2,16509790
5,22.0,Headache,3,16509790
0,22.0,Extravasation,2,16509816
0,22.0,Leukopenia,2,16509828
1,22.0,Neutropenia,2,16509828
2,22.0,Thrombocytopenia,2,16509828
0,22.0,"Hallucination, visual",1,16509832
1,22.0,Metastases to central nervous system,6,16509832
0,22.0,Metastases to central nervous system,6,16509847
1,22.0,Radiation necrosis,6,16509847
0,22.0,Necrotising fasciitis,,16509852
1,22.0,Perirectal abscess,,16509852
2,22.0,Pilonidal cyst,,16509852
0,22.0,Myocardial infarction,6,16509880
0,22.0,Cystitis,3,16509888
1,22.0,Urinary retention,3,16509888
0,22.0,Death,5,16509893
1,22.0,Malignant neoplasm progression,6,16509893
0,22.0,Anxiety,6,16509939
1,22.0,Drug ineffective,3,16509939
2,22.0,Delirium,1,16509939
0,22.0,Disease progression,6,16510029
1,22.0,Prostatic specific antigen increased,6,16510029
0,22.0,Taste disorder,3,16510082
1,22.0,Diarrhoea,3,16510082
2,22.0,Blister,3,16510082
3,22.0,Decreased appetite,3,16510082
4,22.0,Product dose omission,3,16510082
5,22.0,Fatigue,3,16510082
6,22.0,Vomiting,3,16510082
7,22.0,Abdominal pain upper,3,16510082
8,22.0,Stomatitis,3,16510082
9,22.0,Weight decreased,3,16510082
10,22.0,Hypotension,3,16510082
0,22.0,Hypersensitivity,,16510156
1,22.0,Infection,,16510156
0,22.0,Death,,16510212
0,22.0,Anaemia,2,16510220
1,22.0,Off label use,6,16510220
2,22.0,Neutropenia,2,16510220
3,22.0,Leukopenia,2,16510220
0,22.0,Vomiting,2,16510225
1,22.0,Pruritus,2,16510225
2,22.0,Flushing,2,16510225
3,22.0,Band sensation,2,16510225
4,22.0,Paraesthesia,2,16510225
5,22.0,Abdominal pain,2,16510225
6,22.0,Throat tightness,2,16510225
0,22.0,Malignant neoplasm progression,6,16510234
1,22.0,Intentional product use issue,6,16510234
0,22.0,Respiratory failure,6,16510279
1,22.0,Hypertension,6,16510279
2,22.0,Pneumonitis,6,16510279
3,22.0,Seizure,6,16510279
4,22.0,Sepsis,6,16510279
5,22.0,Gastric perforation,5,16510279
0,22.0,Malignant neoplasm progression,5,16510304
1,22.0,Ascites,1,16510304
0,22.0,Death,,16510379
0,22.0,Cerebral infarction,1,16510380
0,22.0,Death,5,16510390
0,22.0,Bone marrow failure,1,16510419
0,22.0,Neoplasm progression,5,16510433
0,22.0,Malignant neoplasm progression,6,16510456
1,22.0,Cystitis,6,16510456
2,22.0,Bladder stenosis,1,16510456
3,22.0,Urinary retention,1,16510456
4,22.0,Fatigue,6,16510456
0,22.0,Metastases to liver,3,16510470
0,22.0,Arteriospasm coronary,1,16510521
1,22.0,Left ventricular dysfunction,1,16510521
0,22.0,Ophthalmoplegia,3,16510529
0,22.0,Aplasia pure red cell,6,16510538
1,22.0,Malaise,6,16510538
0,22.0,Pain,1,16510582
0,22.0,Lip swelling,2,16510629
1,22.0,Gynaecomastia,6,16510629
2,22.0,Hot flush,2,16510629
0,22.0,Cardiac failure,5,16510647
0,22.1,Cytopenia,2,16510678
1,22.1,Intestinal obstruction,2,16510678
0,22.0,Death,5,16510682
0,22.0,Disease progression,,16510758
0,22.0,Blood glucose increased,6,16510774
0,22.0,Bone marrow failure,2,16510784
0,22.0,Bone marrow failure,2,16510816
0,22.1,Rectal haemorrhage,1,16510844
1,22.1,Diarrhoea,1,16510844
2,22.1,Thrombocytopenia,3,16510844
3,22.1,Anaemia,3,16510844
0,22.0,Leukopenia,6,16510847
1,22.0,Neutropenia,6,16510847
0,22.0,General physical health deterioration,1,16511000
1,22.0,Chronic obstructive pulmonary disease,6,16511000
0,22.0,Laryngeal cancer,3,16511141
0,22.0,Abdominal discomfort,1,16511165
1,22.0,Abdominal pain upper,6,16511165
2,22.0,Oral pain,6,16511165
3,22.0,Rash,6,16511165
4,22.0,Dyspnoea,6,16511165
5,22.0,Dysgeusia,6,16511165
6,22.0,Vomiting,2,16511165
7,22.0,Weight decreased,6,16511165
8,22.0,Diarrhoea,6,16511165
9,22.0,Nasal dryness,6,16511165
10,22.0,Emotional disorder,6,16511165
11,22.0,Hypertrophy of tongue papillae,6,16511165
12,22.0,Decreased appetite,6,16511165
13,22.0,Headache,1,16511165
14,22.0,Dry skin,6,16511165
0,22.0,Drug level changed,6,16511218
1,22.0,Nausea,6,16511218
2,22.0,Headache,6,16511218
3,22.0,Seizure,6,16511218
4,22.0,Dizziness,6,16511218
5,22.0,Drug interaction,6,16511218
0,22.0,Dry skin,6,16511409
1,22.0,Pruritus,6,16511409
2,22.0,Thrombocytopenia,6,16511409
0,22.0,Acquired gene mutation,1,16511596
1,22.0,Drug resistance,2,16511596
2,22.0,Malignant neoplasm progression,2,16511596
0,22.0,Thrombocytopenia,6,16512339
1,22.0,Off label use,6,16512339
2,22.0,Leukopenia,6,16512339
0,22.0,Device related thrombosis,2,16512502
0,22.0,Chronic cutaneous lupus erythematosus,1,16512719
0,22.0,Leukopenia,2,16512728
1,22.0,Neutropenia,2,16512728
0,22.0,Nausea,6,16512914
1,22.0,Diarrhoea,6,16512914
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16512914
3,22.0,Weight decreased,6,16512914
4,22.0,Neoplasm progression,6,16512914
5,22.0,Acute kidney injury,6,16512914
6,22.0,Cholestasis,6,16512914
7,22.0,Mucosal inflammation,6,16512914
8,22.0,Fatigue,6,16512914
9,22.0,Dysgeusia,6,16512914
0,22.0,Seizure,6,16512917
1,22.0,Platelet count decreased,6,16512917
2,22.0,Limb injury,6,16512917
3,22.0,Red blood cell count decreased,6,16512917
4,22.0,Joint injury,6,16512917
5,22.0,Face injury,6,16512917
6,22.0,Fall,6,16512917
7,22.0,Gait inability,6,16512917
8,22.0,Hypoaesthesia,6,16512917
9,22.0,Muscle atrophy,6,16512917
0,22.0,Pain in jaw,1,16512920
1,22.0,Nausea,1,16512920
2,22.0,Lower respiratory tract infection,1,16512920
3,22.0,Excessive eye blinking,1,16512920
4,22.0,Diarrhoea,1,16512920
5,22.0,Vomiting,3,16512920
0,22.1,Eustachian tube dysfunction,6,16512926
1,22.1,Arteriosclerosis,6,16512926
2,22.1,Cerebral atrophy,6,16512926
3,22.1,Retention cyst,6,16512926
4,22.1,Headache,6,16512926
5,22.1,Mastoiditis,6,16512926
0,22.0,Myocardial infarction,6,16512933
0,22.0,Nephritis,6,16512948
0,22.0,Headache,2,16512967
1,22.0,Chest pain,2,16512967
2,22.0,Pain,3,16512967
0,22.0,Peripheral swelling,6,16512968
1,22.0,Back pain,1,16512968
2,22.0,Blindness unilateral,6,16512968
3,22.0,Tumour marker increased,2,16512968
0,22.1,Interstitial lung disease,5,16513028
1,22.1,Acute respiratory failure,5,16513028
0,22.0,Septic shock,5,16513089
1,22.0,Agranulocytosis,5,16513089
0,22.0,Metastases to lung,6,16513306
0,22.1,Fatigue,3,16513523
1,22.1,Vomiting,3,16513523
0,22.0,Procedural haemorrhage,5,16513551
0,22.0,Lower respiratory tract infection,5,16513665
1,22.0,Pulmonary embolism,5,16513665
0,22.0,Anaemia,1,16513708
1,22.0,Mucosal dryness,1,16513708
2,22.0,Nausea,1,16513708
3,22.0,Oedema peripheral,1,16513708
4,22.0,Lymphoedema,1,16513708
5,22.0,Fatigue,1,16513708
6,22.0,Epistaxis,1,16513708
0,22.0,Intestinal perforation,6,16513713
1,22.0,Heart rate irregular,6,16513713
2,22.0,Stomatitis,6,16513713
3,22.0,Hypophagia,6,16513713
4,22.0,Gastrointestinal necrosis,6,16513713
5,22.0,Gastrointestinal erosion,5,16513713
6,22.0,Faeces soft,6,16513713
7,22.0,Neuropathy peripheral,2,16513713
0,22.0,Anaemia,6,16513735
1,22.0,Cough,1,16513735
2,22.0,Pneumonitis,6,16513735
3,22.0,Asthenia,6,16513735
0,22.0,Death,5,16513738
0,22.0,Diarrhoea,4,16513759
1,22.0,Gastrointestinal bacterial overgrowth,6,16513759
2,22.0,Coeliac disease,6,16513759
3,22.0,Electrolyte imbalance,6,16513759
4,22.0,Acidosis,6,16513759
0,22.0,Rash generalised,3,16513793
1,22.0,Product use in unapproved indication,6,16513793
0,22.0,Colorectal cancer metastatic,,16513806
1,22.0,Decreased appetite,,16513806
2,22.0,Leukopenia,,16513806
3,22.0,Neutropenia,,16513806
4,22.0,Dysphonia,,16513806
0,22.0,Ulcer,1,16513878
1,22.0,Pain,1,16513878
2,22.0,Calciphylaxis,1,16513878
0,22.0,Malignant neoplasm progression,6,16513893
1,22.0,Drug resistance,6,16513893
